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1. Introduction 
Heparin is a glycosaminoglycan with unique 
biological properties, such as the ability to prevent 
blood from clotting. This anticoagulant activity is 
largely or wholly due to the interaction between 
plasma antithrombin (antithrombin III) and 
heparin, leading to an increased rate of inactivation 
of a number of the enzymes involved in the 
coagulation mechanism [ 1,2]. It has not been 
possible to define the structural properties responsible 
for the antithrombin-activating effect of heparin, 
although certain features such as a minimal mol. wt. 
and a high degree of N-sulfation appear to be 
essential [3,4]. 
In the present study heparin was separated by 
affinity chromatography on antithrombin-substituted 
Sepharose into two distinct fractions, one with high 
affinity and one with little or no affinity for the 
protein. The anticoagulant activities of the two 
fractions differed greatly, the high-affinity fraction 
having about 300 B.P. units/mg whereas the low- 
affinity fraction was almost inactive. A preliminary 
characterization of the two heparin fractions failed 
to reveal any structural dissimilarities, apart from a 
slight difference in charge density. 
2. Materials and methods 
Heparin (stage 14, isolated from pig intestinal 
mucosa), obtained from Inolex Pharmaceutical Div., 
Park Forest South, Ill., USA, was purified by 
repeated precipitation with cetylpyridinium chloride 
90 
from 1.2 M NaCI, essentially as described elsewhere 
[5]. The purified material had an anticoagulant 
activity of 190 B.P. units/mg. 
Radioactive heparin was isolated from mouse 
mastocytoma tissue, after labeling in viva with 
inorganic [35S]sulfate [6] or in vitro with [‘4C]glu- 
case [7]. 
Purified human thrombin with a stated activity 
of about 2500 NIH units/mg was kindly given by 
Dr M. Miller-Andersson, AB Kabi, Stockholm. 
Human and bovine antithrombin were isolated 
from plasma by affinity chromatography on 
heparinSepharose and further purified by ion 
exchange chromatography and gel chromatography 
[8]. Bovine antithrombin was coupled to Sepharose 
and used as affinity matrix, as described below; 
human antithrombm was used only in the heparin 
activity assays. 
Purified bovine antithrombin was coupled via 
amino groups to cyanogen bromide-activated 
Sepharose 4B (Pharmacia Fine Chemicals, Uppsala, 
Sweden) in the presence of excess amounts of 
heparin. The heparin (‘previously treated with 
acetic anhydride [9] in order to acetylate any free 
amino groups present) was added as an attempt 
to shield the heparin-binding site of the antithrombin 
molecule from binding to the Sepharose beads. 
Activated Sepharose (5 ml) was reacted at pH 8.0 
[lo] with 50 mg of antithrombin in the presence 
of 300 mg of heparin. Ammo acid analysis of the 
antithrombin-substituted Sepharose indicated a 
protein content of about 7 mg/ml of fmal gel sus- 
pension. 
North-Holland Acblishing Company - Amsterdam 
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Methods for the determination of uranic acid 
and radioactivity have been described [ 111. The dry- 
weight of heparin samples was determined after 
drying over magnesium perchlorate in vacua to 
constant weight. Duplicate samples invariably 
differed by less than 5%. 
Anticoagulant activities were determined by the 
British Pharmacopoeia (B.P.) whole-blood assay 
[ 121. Alternatively, the antithrombin-activating 
effect of heparin was measured by a procedure, 
based on the heparin cofactor activity method 
developed by odegird et al. [ 131; the procedure 
is outlined in the legend to fig.2, and will be 
described in detail elsewhere. 
Affinity chromatography of heparin on immo- 
bilized antithrombin was carried out as follows. 
Samples of heparin in 1 ml of 0.2 M NaCl-0.1 M 
Tris-HCl, pH 7.4, were applied to a column 
containing 3 ml of antithrombin-Sepharose gel, 
equilibrated with the same buffer at 4°C. The 
column was washed with buffer until the effluent 
was free from uranic acid or radioactivity, and 
was then eluted with a linear salt gradient (for 
further details, see the legend to tig.1). Effluent 
fractions were analyzed for uranic acid by the 
carbazole reaction and/or for radioactivity. Appropriate 
fractions were pooled, dialyzed against water and 
lyophilized. Samples were precipitated with 
cetylpyridinium chloride from 1 M NaCl and 
recovered as sodium salts [S] before determination 
of anticoagulant activity. 
3. Results and discussion 
3.1. Affinity chromatography of heparin on 
antithrombirdepharose 
The fractionation of 1 mg of heparin by affinity 
chromatography on antithrombin-Sepharose is 
illustrated in fig.1. A portion of the material 
appeared in the breakthrough-fraction (0.2 M NaCl 
wash) while another portion emerged uring 
gradient elution. The latter component comprised 
38% of the uranic acid-containing material 
recovered from the gel; with 35 S- or “C-labeled 
heparin the corresponding values were 64% and 
50%, respectively. The total recovery of radio- 
activity and uranic acid was invariably better than 
90% of the material applied to the column. 
50 100 
EFFLUENT VOLUME kl) 
Fig.1. Chromatography of heparin on antithrombin- 
Sepharose. A sample (1 mg) of heparin, dissolved in 1 ml 
of 0.2 M NaCl-0.1 M Tris-HCl, pH 7.4, was applied to a 
3 ml-column of antithrombin-Sepharose, quilibrated with 
the same buffer at 4°C. After washing with 40 ml of 
buffered 0.2 M NaCl, the column was eluted with sodium 
chloride (linear gradient from 0.2 M to 3 M concentration) 
in 0.1 M Tris-HCl, pH 7.4. Effluent fractions were analyzed 
for uranic acid by the carbazole reaction (_4 &, 
(- - - - - -) NaCl concentration. 
Re-chromatography of once adsorbed, eluted and 
dialyzed heparin resulted in quantitative retention of 
the material by the gel. Conversely, the breakthrough 
fraction did not yield any adsorbed components on 
re-application to the gel. These results how the 
occurrence of at least wo types of heparin, differing 
markedly in their affinity for antithrombin. 
In preparative experiments, the antithrombin- 
Sepharose column was deliberately overloaded by 
applying 8 mg portions of heparin to 3 ml of gel. 
After extensive washing with buffered 0.2 M NaCl, 
the adsorbed polysaccharide was eluted in a single 
step with buffered 3 M NaCl. When the breakthrough 
fraction was reapplied to the antithrombin-Sepharose 
column (re-equilibrated with buffered 0.2 M NaCl) 
another portion of material was retained by the gel 
and could be eluted by salt. Three such successive 
passages through the gel, removing progressively 
smaller amounts of material, were required to 
virtually deplete the heparin solution of components 
having affinity for the column under the conditions 
used. The analyses which follow refer either to 
material eluted with salt after an initial passage 
of heparin solution through the antithrombin- 
Sepharose column (high-affinity heparin), or to 
heparin depleted of such components by three 
91 
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Table 1 
Anticoagulant activity (B.P. method) and uranic acid content of heparin, before.and 
after fractionation on antithrombin-Sepharose 
Preparation Anticoagulant activity 
Recoverya (B.P. units/mg dry weight) 
Uranic acid content 
(% of dry weight) 
Starting material 
Low-affinity 
fraction 
High-affinity 
fraction 
100 190 29.2 
7 19 24.6 
54 285 29.9 
a Per cent of starting material. 
successive passages through the column (low-affinity 
heparin). 
4.2. Anticoagulant activity of high- and low-affinity 
heparin 
The anticoagulant activities (B.P. method) of 
heparin, measured before and after fractionation on 
the antithrombin-Sepharose gel, are shown in table 1. 
High-affinity heparin displayed exceptionally high 
activity; in contrast, low-affinity heparin was almost 
inactive. Essentially similar relations were found by 
the antithrombin-activation assay (fig.2); however, 
low-affinity heparin showed higher activity relative 
to the starting material than in the B.P. procedure. 
In spite of almost complete recovery of uranic 
acid, the high-affinity and low-affmity heparin 
fractions only accounted for approx. 60% of the 
anticoagulant activity (B.P. units) of the starting 
material. The reason for this discrepancy is unknown. 
Recombination of the two fractions did not 
increase the activity beyond the calculated sum. 
4.3. Structures of high- and low-affinity heparins 
The ratio of N-sulfate to total sulfate was 
determined with [35S]heparin, by paper electropho- 
retie. separation of deamination products [ 141; the 
values obtained were 0.36 and 0.32 for high- and 
low-affinity heparin, respectively. Further, the two 
heparin fractions displayed similar distribution of 
N-sulfate groups, as judged from the elution 
profiles obtained on gel chromatography [ 1 I] of 
deamination products. Paper electrophoresis (pH 
1.7; ref. [I 11) of deamination products derived 
from high- and low-affinity [35S]heparin revealed 
approx. similar relative amounts of mono- and 
92 
di-O-sulfated disaccharide units. Finally, the uranic 
acid composition of [r4C]heparin was determined 
[15] ; the ratio of [r4C]iduronic acid to total 
[‘4C]uronic acid was 0.49 and 0.58 for high- and 
low-affinity heparin, respectively. 
These results indicate that both the high- and 
the low-affinity materials conform to the current 
structural concept of heparin; however, they do not 
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Fig.2. Antithrombin-activating properties of heparin, 
before and after chromatography on antithrombin-Sepharose. 
(0) Starting material; (0) high-affinity heparin; (u) 
low-affinity heparin. Samples (100 r.11) of antithrombin 
solution (50 pi/ml) and of heparin solutions of different 
concentrations were mixed and incubated for 5 min at 
37°C. Thrombin (50 ~1 of a solution containing 90 NIH 
units/ml) was then added, and after additional incubation 
for 20 set the remaining thrombin activity was measured 
by recording the release of p-nitroaniline (absorbing at 
405 nm) from the synthetic thrombin substrate, 
Bz-Phe-Val-Arg-pNS (S-2160; AB Kabi, Sweden). The 
results are expressed as nkat thrombin inhibited; under 
the conditions of the assay this parameter is a function of 
the heparin.activity. 
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reveal the cause of the difference in antithrombm 
affinity and anticoagulant activity. Gel chromato- 
graphy on Sephadex G-100 also failed to distinguish 
between the two preparations, howing essentially 
similar molecular-size distributions. In contrast, on 
ion-exchange chromatography (DEAE-cellulose; 
see [ 111) the low-affinity heparin emerged 
slightly but distinctly ahead of the high-affinity 
heparin, suggesting a somewhat higher net negative 
charge density in the latter material. The significance 
of this finding is unknown. 
After conclusion of the present study a report 
appeared, showing the fractionation of heparin into 
two distinct forms by sucrose density gradient 
centrifugation i  the presence of antithrombin [ 161. 
The two fractions appear similar to the heparin 
fractions obtained by affinity chromatography; 
apparently, the separation of high-activity heparin 
from low-activity heparin may be accomplished by 
either procedure. The antithrombin-Sepharose 
method is the more suitable one for large-scale 
separations; in recent experiments he procedure 
has been successfully scaled up to achieve fractionat- 
ion of 50 mg of heparin in a single run. 
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